GlaxoSmithKline PLC Company Profile (NYSE:GSK)

Analyst Ratings

Consensus Ratings for GlaxoSmithKline PLC (NYSE:GSK) (?)
Ratings Breakdown: 1 Sell Rating(s), 10 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Hold (Score: 2.37)
Consensus Price Target: $47.25 (4.84% upside)

Analysts' Ratings History for GlaxoSmithKline PLC (NYSE:GSK)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2016Shore CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016Jefferies GroupUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Deutsche Bank AGReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016Bank of America Corp.Reiterated RatingBuy$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Beaufort SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Oddo SecuritiesUpgradeReduce -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Cantor FitzgeraldInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Sanford C. BernsteinBoost Price TargetMarket Perform$43.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Bryan, Garnier & CoUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/21/2015Leerink SwannReiterated RatingMarket Perform$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015ArgusLower Price TargetBuy$52.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Morgan StanleyReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/31/2015Societe GeneraleReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/20/2015Credit Suisse Group AGUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015BNP ParibasUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015Liberum CapitalUpgradeSell -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2015HSBCInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2015Berenberg BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Barclays PLCReiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015Kepler Capital MarketsReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015Panmure GordonReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2015S&P Equity ResearchDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015New Street ResearchDowngradeReduceView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2014KillikReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2014Galvan ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for GlaxoSmithKline PLC (NYSE:GSK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
2/3/2016Q415$0.18$0.18$6.28 billion$6.29 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q3$0.60$0.71$6.07 billion$6.13 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q215$0.50$0.53ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.55$0.48ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2015Q414$0.86$0.82$6.14 billion$6.19 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014Q314$0.79$0.90ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q114$0.71$0.65ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q413$0.72$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2014Q4$0.30$0.30$6.84 billion$6.91 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313$0.31$10.31 billion$10.09 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2013$0.26$0.26$6.62 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2012$0.29$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2012$0.30$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GlaxoSmithKline PLC (NYSE:GSK)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.50$0.50$0.50
Q2 20162$0.54$0.55$0.55
Q3 20161$0.75$0.75$0.75
Q4 20161$0.70$0.70$0.70
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for GlaxoSmithKline PLC (NYSE:GSK)
Annual Dividend:$1.98
Dividend Yield:4.39%
Payout Ratio:6,600.00% (Based on Trailing 12 Months of Earnings)
86.84% (Based on Current Year Consensus EPS Estimate)
75.00% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:2.50% (3 Year Average)

Dividend History for GlaxoSmithKline PLC (NYSE:GSK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
7/27/2016$0.498/10/20168/12/201610/13/2016Tweet This Announcement  Share This Announcement on StockTwits
4/28/2016$0.555/11/20165/13/20167/14/2016Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015$0.5811/10/201511/13/20151/14/2016Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015quarterly$0.585.22%5/13/20155/15/20157/9/2015Tweet This Announcement  Share This Announcement on StockTwits
2/5/2015quarterly$0.706.05%2/18/20152/20/20154/9/2015Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014quarterly$0.615.41%11/5/201411/7/20141/8/2015Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014quarterly$0.655.18%8/6/20148/8/201410/2/2014Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014quarterly$0.644.62%5/14/20145/16/20147/10/2014Tweet This Announcement  Share This Announcement on StockTwits
2/5/2014$0.752/19/20142/21/20144/10/2014Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014quarterly$0.755.73%2/19/20142/21/20144/10/2014Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013quarterly$0.624.76%11/13/201311/15/20131/9/2014Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013quarterly$0.554.27%8/7/20138/9/201310/3/2013Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013quarterly$0.554.25%5/8/20135/10/20137/11/2013Tweet This Announcement  Share This Announcement on StockTwits
2/7/2013quarterly$0.070.61%2/20/20132/22/20134/11/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for GlaxoSmithKline PLC (NYSE:GSK)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for GlaxoSmithKline PLC (NYSE:GSK)
DateHeadline
07/28/16 03:07 PMGlaxoSmithKline : Pharma giant GSK in 110 million Montrose investment
07/28/16 03:07 PMDeutsche Bank recorded (LON:GSK) GlaxoSmithKline PLC, renewing its price target at 1,700GBX earlier today
07/28/16 03:07 PMGlaxo (GSK) Beats Q2 Earnings Estimates, Revenues Up Y/Y
07/28/16 03:07 PMGlaxoSmithKline plc (NYSE:GSK) To Invest $360 Million In Britain Amid Brexit Concerns
07/28/16 07:13 AMStock Earnings Estimates in Limelight: GlaxoSmithKline plc (ADR) (NYSE:GSK) - Post Registrar
07/28/16 04:01 AMAstraZeneca Earnings, Sales Edge Above Forecasts -
07/27/16 11:11 PM[$$] GlaxoSmithKline Helped and Hurt by Sterling’s Post-Brexit Fall -
07/27/16 04:33 PMGlaxoSmithKline plc Beats on Revenue; Invests in New Respiratory Drug - Bidness ETC
07/27/16 07:04 AMAnalyst Rating Fluctuations to Observe: GlaxoSmithKline PLC (NYSE:GSK) , Globus Medical, Inc. (NYSE:GMED) - Street Updates
07/26/16 04:31 PMGlaxoSmithKline plc (ADR) Earning Release; Here's What to Expect - Business Finance News
07/25/16 04:23 PMWhat the "Andrew Witty phase" has meant for GSK in India
07/25/16 08:56 AMGlaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?
07/22/16 04:16 PMGlaxoSmithKline plc : half-yearly earnings release
07/22/16 03:09 PMGlaxoSmithKline's Sideways Dance May Pay Off in the Long Run -
07/22/16 02:39 PMGlaxoSmithKline Segments That Drive Company’s Rising Revenues -
07/22/16 02:39 PMGSK’s HIV Products Expected to Have Driven 2Q Earnings -
07/22/16 02:10 PMBioFlash podcast: Why Big Pharma is hungry for bacteria -
07/22/16 09:07 AMHuge Drugmaker Fines for Bribing Healthcare Providers -
07/22/16 07:15 AMEarnings Focus and Crowd Sourced Sentiment Review for GlaxoSmithKline PLC (NYSE:GSK) - TGP
07/22/16 07:15 AMIt's Earnings Time: What to Do with GlaxoSmithKline plc (NYSE:GSK) Stock - The Voice Registrar
07/21/16 12:49 PMInside the Foreign Exchange Impact on Novartis’s Growth in 2Q16 -
07/21/16 12:49 PMHow Did Novartis’s 2Q16 Earnings Stand up to Analyst Estimates? -
07/21/16 07:52 AMHC Stocks Buzzer: GlaxoSmithKline plc (ADR) (NYSE:GSK), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - share market updates (press release)
07/20/16 05:43 PMHC Stocks Momentum: GlaxoSmithKline plc (ADR) (NYSE:GSK), Horizon Pharma PLC (NASDAQ:HZNP) - share market updates (press release)
07/20/16 02:52 PM3:52 pm GlaxoSmithKline begins shipping quadrivalent vaccine doses to US healthcare providers, following licensing and lot-release approval from the FDA's Center for Biologics Evaluation and Research -
07/20/16 02:51 PMGSK ships 2016-17 seasonal influenza vaccines for US market - [PR Newswire] - PHILADELPHIA, July 20, 2016 /PRNewswire/ -- GSK announced today it has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and lot-release approval ...
07/20/16 10:00 AMVBIV: A Differentiated Immunology Company With Multiple Near Term Value Drivers -
07/20/16 07:11 AMBroker Outlook For GlaxoSmithKline PLC (NYSE:GSK) - Fiscal Standard
07/20/16 07:11 AMGlaxoSmithKline PLC (LON:GSK) Shares Rise as Shore Capital Reiterates Hold Rating - Press Telegraph
07/19/16 04:25 PMGSK to use Apple’s iPhone popularity for arthritis study development
07/19/16 11:05 AMWhere GSK ranks in R&D spending against sales and marketing -
07/19/16 10:25 AMLong Term Value Play: GlaxoSmithKline plc (NYSE:GSK) - TGP
07/19/16 10:25 AMGlaxoSmithKline (NYSE:GSK) & Accenture Plc (NYSE:ACN) Stock's Trend Analysis Report - Money News (press release)
07/19/16 10:25 AMHC Stocks Outlines: GlaxoSmithKline plc (ADR) (NYSE:GSK), Opko Health Inc. (NYSE:OPK) - share market updates (press release)
07/19/16 10:25 AMAnalyst's Checklist Stocks: GlaxoSmithKline PLC (NYSE:GSK) , Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Street Updates
07/19/16 10:25 AMGlaxoSmithKline plc (NYSE:GSK) Receives Approval For HPV Vaccine In China - Market Exclusive
07/19/16 08:25 AMNovartis in no rush to sell down stake on GSK consumer venture -
07/18/16 04:31 PMGlaxoSmithKline is first drugmaker to use Apple’s ResearchKit
07/18/16 08:45 AMWhy Novartis’s 2Q16 Revenues Are Expected to Fall -
07/18/16 08:45 AMNovartis’s 2Q16 Earnings: What’s Expected? -
07/17/16 03:55 PMCredit Suisse issued a report on (LON:GSK) GlaxoSmithKline PLC, renewing its price target at 1,440GBX earlier today
07/15/16 07:25 AMKeep an eye on Analyst Actions: GlaxoSmithKline PLC (NYSE:GSK) , Allergan plc. (NYSE:AGN) - Street Updates
07/14/16 04:28 PMGlaxoSmithKline : *JEFFERIES RAISES GLAXOSMITHKLINE TO 'BUY' (HOLD) - PRICE TARGET 2000 PENCE
07/14/16 04:28 PMIs the CDO a threat to the CIO? | #MITCDOIQ
07/14/16 04:28 PMAnalysts At JP Morgan Maintained GlaxoSmithKline PLC (LON:GSK) As Neutral - Fiscal Standard
07/14/16 04:28 PMUpdate on GlaxoSmithKline plc (NYSE:GSK) for the day - Twin County News
07/14/16 08:44 AMGlaxo Gains Jefferies Upgrade on Stronger HIV Drugs Performance, Currency Benefits -
07/14/16 08:44 AMGlaxo Gains Jefferies Upgrade on Stronger HIV Drugs Performance, Currency Benefits -
07/14/16 07:47 AMGlaxoSmithKline plc 20% Potential Upside Indicated by Jefferies International - DirectorsTalk Interviews
07/14/16 07:47 AMTraders Observable Stocks: AbbVie Inc. (NYSE:ABBV) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates

Social

About GlaxoSmithKline PLC

GlaxoSmithKline PLC logoGlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic diseases. Its human immunodeficiency virus (HIV) business is managed through ViiV Healthcare. GSK's Vaccines has a portfolio of over 30 paediatric, adolescent, adult travel vaccines. GSK's Established Products Portfolio includes over 50 off-patent products, as well as its branded generics business and other local products. The Consumer Healthcare business develops and markets products in four categories, such as wellness, oral health, nutrition and skin health. Its brands include Sensodyne, Panadol, Horlicks, Polident, Paradontax, Tums, ENO, NiQuitin/Nicorette, Abreva, Zovirax and Aquafresh. It operates in the United Kingdom, the United States, Belgium and China.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: GSK
  • CUSIP:
Key Metrics:
  • Previous Close: $45.07
  • 50 Day Moving Average: $42.69
  • 200 Day Moving Average: $41.45
  • P/E Ratio: 135.75
  • P/E Growth: 33.03
  • Market Cap: $109.48B
  • Beta: 0.79
  • Current Year EPS Consensus Estimate: $2.28 EPS
  • Next Year EPS Consensus Estimate: $2.64 EPS
Additional Links:
GlaxoSmithKline PLC (NYSE:GSK) Chart for Friday, July, 29, 2016